• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II和激肽受体拮抗剂对卡托普利肾血流动力学反应的影响。

Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.

作者信息

Fenoy F J, Scicli G, Carretero O, Roman R J

机构信息

Department of Physiology, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Hypertension. 1991 Jun;17(6 Pt 2):1038-44. doi: 10.1161/01.hyp.17.6.1038.

DOI:10.1161/01.hyp.17.6.1038
PMID:1646165
Abstract

The role of angiotensin II and kinins on the renal cortical and papillary hemodynamic and on the sodium and water excretory responses to converting enzyme inhibition with captopril was examined in euvolemic Munich-Wistar rats. Cortical and papillary blood flows were measured using a laser Doppler flowmeter. Cortical blood flow increased 28% after blockade of angiotensin II receptors with DuP 753 (2 mg/kg i.v., n = 6). Captopril (2 mg/kg i.v., n = 6) had no effect on cortical blood flow in rats pretreated with the angiotensin II antagonist. DuP 753 had no effect on papillary blood flow, nor did it prevent the rise in papillary blood flow produced by captopril (2 mg/kg, n = 6). Infusion of a kinin receptor antagonist, D-Arg, [Hyp3,Thi5,8,D-Phe7]-bradykinin (2.5 micrograms/min i.v.), reduced basal papillary blood flow by 15% and blocked the rise in papillary blood flow produced by captopril. Renal blood flow rose by 11% after DuP 753 (2 mg/kg, n = 6), and subsequent administration of captopril and the kinin antagonist had no effect on renal blood flow. Urine flow and sodium excretion increased after DuP 753, but captopril produced additional increases in urine flow and sodium excretion of 68% and 46% respectively. Fractional sodium excretion rose from 0.85 +/- 0.15% to 1.56 +/- 0.14% after captopril. Infusion of the kinin antagonist returned sodium and water excretion to control levels, but fractional sodium excretion was not significantly altered. Glomerular filtration rate was not altered by DuP 753 or captopril; however, it fell from 1.6 +/- 0.1 to 1.2 +/- 0.1 ml/min/g kidney wt during infusion of the kinin antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在血容量正常的慕尼黑-威斯塔大鼠中,研究了血管紧张素II和激肽对肾皮质和肾乳头血流动力学以及对卡托普利抑制转化酶后钠和水排泄反应的作用。使用激光多普勒血流仪测量皮质和乳头血流。用杜普753(2毫克/千克静脉注射,n = 6)阻断血管紧张素II受体后,皮质血流增加28%。在预先用血管紧张素II拮抗剂处理的大鼠中,卡托普利(2毫克/千克静脉注射,n = 6)对皮质血流无影响。杜普753对乳头血流无影响,也不能阻止卡托普利(2毫克/千克,n = 6)引起的乳头血流增加。输注激肽受体拮抗剂D-精氨酸,[Hyp3,Thi5,8,D-苯丙氨酸7]-缓激肽(2.5微克/分钟静脉注射)使基础乳头血流降低15%,并阻断了卡托普利引起的乳头血流增加。杜普753(2毫克/千克,n = 6)后肾血流增加11%,随后给予卡托普利和激肽拮抗剂对肾血流无影响。杜普753后尿流量和钠排泄增加,但卡托普利分别使尿流量和钠排泄额外增加68%和46%。卡托普利后钠排泄分数从0.85±0.15%升至1.56±0.14%。输注激肽拮抗剂使钠和水排泄恢复到对照水平,但钠排泄分数无显著改变。肾小球滤过率不受杜普753或卡托普利影响;然而,在输注激肽拮抗剂期间,它从1.6±0.1降至1.2±0.1毫升/分钟/克肾重。(摘要截断于250字)

相似文献

1
Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.血管紧张素II和激肽受体拮抗剂对卡托普利肾血流动力学反应的影响。
Hypertension. 1991 Jun;17(6 Pt 2):1038-44. doi: 10.1161/01.hyp.17.6.1038.
2
Role of kinins and angiotensin II in the renal hemodynamic response to captopril.激肽和血管紧张素II在肾脏对卡托普利血流动力学反应中的作用。
Am J Physiol. 1991 May;260(5 Pt 2):F670-9. doi: 10.1152/ajprenal.1991.260.5.F670.
3
Influence of kinins and angiotensin II on the regulation of papillary blood flow.激肽和血管紧张素II对乳头血流调节的影响。
Am J Physiol. 1988 Oct;255(4 Pt 2):F690-8. doi: 10.1152/ajprenal.1988.255.4.F690.
4
Kinin contribution to renal vasodilator effect of captopril in rabbit.激肽对卡托普利在兔体内肾血管舒张作用的影响。
Hypertension. 1991 Apr;17(4):504-9. doi: 10.1161/01.hyp.17.4.504.
5
Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion.
Am J Physiol. 1992 Nov;263(5 Pt 2):R1136-40. doi: 10.1152/ajpregu.1992.263.5.R1136.
6
Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.实验性糖尿病中激肽释放酶-激肽系统与肾素-血管紧张素系统的相互作用
Diabetes. 1997 Jan;46(1):107-12. doi: 10.2337/diab.46.1.107.
7
Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.血管紧张素转换酶抑制对循环和局部激肽水平的影响。
Am J Cardiol. 1982 Apr 21;49(6):1401-4. doi: 10.1016/0002-9149(82)90350-2.
8
Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.血管紧张素转换酶抑制后肾脏血流动力学与肾脏激肽
Kidney Int. 1981 Nov;20(5):615-20. doi: 10.1038/ki.1981.184.
9
Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.血管紧张素II受体阻滞剂EXP 3174与血管紧张素转换酶抑制剂卡托普利对犬肾小球血流动力学的比较效应。
Kidney Blood Press Res. 1997;20(6):391-7. doi: 10.1159/000174256.
10
Kinin actions on renal papillary blood flow and sodium excretion.激肽对肾乳头血流及钠排泄的作用。
Hypertension. 1993 Jun;21(6 Pt 2):961-5. doi: 10.1161/01.hyp.21.6.961.

引用本文的文献

1
Divergent roles of angiotensin II upon the immediate and sustained increases of renal blood flow following unilateral nephrectomy.血管紧张素 II 在单侧肾切除术后即刻和持续增加肾血流量中的不同作用。
Am J Physiol Renal Physiol. 2022 May 1;322(5):F473-F485. doi: 10.1152/ajprenal.00376.2021. Epub 2022 Feb 28.
2
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.基于新发展理念的治疗盐敏感性高血压的新型抗高血压药物类别
Pharmaceuticals (Basel). 2010 Jan 7;3(1):59-109. doi: 10.3390/ph3010059.
3
Effects of pH and medullary blood flow on oxygen transport and sodium reabsorption in the rat outer medulla.
pH 值和髓质血流量对大鼠外髓氧运输和钠重吸收的影响。
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1369-83. doi: 10.1152/ajprenal.00572.2009. Epub 2010 Mar 24.
4
Renal medullary oxidative stress, pressure-natriuresis, and hypertension.肾髓质氧化应激、压力性利钠作用与高血压。
Hypertension. 2008 Nov;52(5):777-86. doi: 10.1161/HYPERTENSIONAHA.107.092858. Epub 2008 Oct 13.
5
Vascular remodeling and the kallikrein-kinin system.血管重塑与激肽释放酶-激肽系统
J Clin Invest. 2005 Mar;115(3):588-91. doi: 10.1172/JCI24567.
6
ACE inhibitors and proteinuria.血管紧张素转换酶抑制剂与蛋白尿
Pharm World Sci. 1996 Dec;18(6):204-10. doi: 10.1007/BF00735961.
7
Renal hemodynamic response to ureteral obstruction during converting enzyme inhibition.
Urol Res. 1996;24(4):217-27. doi: 10.1007/BF00295895.
8
Molecular aspects of kallikrein and kininogen in the maturing kidney.成熟肾脏中激肽释放酶和激肽原的分子层面研究
Pediatr Nephrol. 1993 Oct;7(5):646-51. doi: 10.1007/BF00852573.
9
The effect of kinin and prostaglandin inhibitors on the renal response to angiotensin-converting enzyme inhibition: a micropuncture study in the dog.激肽和前列腺素抑制剂对肾脏对血管紧张素转换酶抑制反应的影响:犬的微穿刺研究
Pflugers Arch. 1994 Jun;427(3-4):219-24. doi: 10.1007/BF00374527.
10
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.依那普利与β受体阻滞剂用于非糖尿病性慢性肾衰竭的随机对照试验
BMJ. 1994 Oct 1;309(6958):833-7. doi: 10.1136/bmj.309.6958.833.